• Please log in or register to access this feature.

Review

You have free access to this content

Correlating Multiallelic Copy Number Polymorphisms with Disease Susceptibility

  1. Stuart Cantsilieris1,2,
  2. Stefan J. White1,*

Article first published online: 23 AUG 2012

DOI: 10.1002/humu.22172

Issue

Human Mutation

Human Mutation

Volume 34, Issue 1, pages 1–13, January 2013

Additional Information

How to Cite

Cantsilieris, S. and White, S. J. (2013), Correlating Multiallelic Copy Number Polymorphisms with Disease Susceptibility. Hum. Mutat., 34: 1–13. doi: 10.1002/humu.22172

Author Information

  1. 1

    Centre for Reproduction and Development, Monash Institute of Medical Research, Monash University, Melbourne, Victoria, Australia

  2. 2

    Centre for Eye Research Australia, University of Melbourne, Royal Victorian Eye and Ear Hospital, East Melbourne, Victoria, Australia

* Correspondence to: Stefan J. White, Centre for Reproduction and Development, Monash Institute of Medical Research, 27-31 Wright Street, Clayton, 3168, Victoria, Australia. E-mail: stefan.white@monash.edu

  1. Communicated by Arupa Ganguly

  2. Contract grant sponsors: Monash University, Melbourne; National Health and Medical Research Council of Australia.

Publication History

  1. Issue published online: 20 DEC 2012
  2. Article first published online: 23 AUG 2012
  3. Accepted manuscript online: 26 JUL 2012 02:32PM EST
  4. Manuscript Accepted: 13 JUL 2012
  5. Manuscript Received: 28 MAY 2012

Funded by

  • Monash University, Melbourne
  • National Health and Medical Research Council of Australia

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (354K)

References

  • Ahuja SK, Kulkarni H, Catano G, Agan BK, Camargo JF, He W, O'Connell RJ, Marconi VC, Delmar J, Eron J, Clark RA, Frost S, et al. 2008. CCL3L1-CCR5 genotype influences durability of immune recovery during antiretroviral therapy of HIV-1-infected individuals. Nat Med 14:413–420.
  • Aitman TJ, Dong R, Vyse TJ, Norsworthy PJ, Johnson MD, Smith J, Mangion J, Roberton-Lowe C, Marshall AJ, Petretto E, Hodges MD, Bhangal G, et al. 2006. Copy number polymorphism in Fcgr3 predisposes to glomerulonephritis in rats and humans. Nature 439:851–855.
  • Aldhous MC, Abu Bakar S, Prescott NJ, Palla R, Soo K, Mansfield JC, Mathew CG, Satsangi J, Armour JAL. 2010. Measurement methods and accuracy in copy number variation: failure to replicate associations of beta-defensin copy number with Crohn's disease. Hum Mol Genet 19:4930–4938.
  • Alkan C, Coe BP, Eichler EE. 2011a. Genome structural variation discovery and genotyping. Nat Rev Genet 12:363–376.
  • Alkan C, Kidd JM, Marques-Bonet T, Aksay G, Antonacci F, Hormozdiari F, Kitzman JO, Baker C, Malig M, Mutlu O, Sahinalp SC, Gibbs RA, et al. 2009. Personalized copy number and segmental duplication maps using next-generation sequencing. Nat Genet 41:1061–1067.
  • Alkan C, Sajjadian S, Eichler EE. 2011b. Limitations of next-generation genome sequence assembly. Nat Methods 8:61–65.
  • Armour JA, Palla R, Zeeuwen PLJM, Heijer Md, Schalkwijk J, Hollox EJ. 2007. Accurate, high-throughput typing of copy number variation using paralogue ratios from dispersed repeats. Nucleic Acids Res 35:e19.
  • Armour JAL, Sismani C, Patsalis PC, Cross G. 2000. Measurement of locus copy number by hybridisation with amplifiable probes. Nucleic Acids Res 28:605–609.
  • Bailey JA, Gu Z, Clark RA, Reinert K, Samonte RV, Schwartz S, Adams MD, Myers EW, Li PW, Eichler EE. 2002. Recent segmental duplications in the human genome. Science 297:1003–1007.
  • Barnes C, Plagnol V, Fitzgerald T, Redon R, Marchini J, Clayton D, Hurles ME. 2008. A robust statistical method for case-control association testing with copy number variation. Nat Genet 40:1245–1252.
  • Bentley RW, Pearson J, Gearry RB, Barclay ML, McKinney C, Merriman TR, Roberts RL. 2010. Association of higher DEFB4 genomic copy number with Crohn's disease. Am J Gastroenterol 105:354–359.
  • Bhattacharya T, Stanton J, Kim EY, Kunstman KJ, Phair JP, Jacobson LP, Wolinsky SM. 2009. CCL3L1 and HIV/AIDS susceptibility. Nat Med 15:1112–1115.
  • Boteva L, Morris David L, Cortés-Hernández J, Martin J, Vyse Timothy J, Fernando Michelle MA. 2012. Genetically determined partial complement C4 deficiency states are not independent risk factors for SLE in UK and Spanish populations. Am J Hum Genet 90:445–456.
  • Breunis WB, van Mirre E, Bruin M, Geissler J, de Boer M, Peters M, Roos D, de Haas M, Koene HR, Kuijpers TW. 2008. Copy number variation of the activating FCGR2C gene predisposes to idiopathic thrombocytopenic purpura. Blood 111:1029–1038.
  • Breunis WB, van Mirre E, Geissler J, Laddach N, Wolbink G, van der Schoot E, de Haas M, de Boer M, Roos D, Kuijpers TW. 2009. Copy number variation at the FCGR locus includes FCGR3A, FCGR2C and FCGR3B but not FCGR2A and FCGR2B. Hum Mutat 30:E640–E650.
    Direct Link:
  • Burns JC, Shimizu C, Gonzalez E, Kulkarni H, Patel S, Shike H, Sundel RS, Newburger JW, Ahuja SK. 2005. Genetic variations in the receptor-ligand pair CCR5 and CCL3L1 are important determinants of susceptbility to Kawasaki disease. J Infect Dis 192:344.
  • Campbell CD, Sampas N, Tsalenko A, Sudmant PH, Kidd JM, Malig M, Vu TH, Vives L, Tsang P, Bruhn L, Eichler EE. 2011. Population-genetic properties of differentiated human copy-number polymorphisms. Am J Hum Genet 88:317–332.
  • Carpenter D, Walker S, Prescott N, Schalkwijk J, Armour J. 2011. Accuracy and differential bias in copy number measurement of CCL3L1 in association studies with three auto-immune disorders. BMC Genomics 12:418.
  • Clayton DG, Walker NM, Smyth DJ, Pask R, Cooper JD, Maier LM, Smink LJ, Lam AC, Ovington NR, Stevens HE. 2005a. Population structure, differential bias and genomic control in a large-scale, case-control association study. Nat Genet 37:1243–1246.
  • Clayton DG, Walker NM, Smyth DJ, Pask R, Cooper JD, Maier LM, Smink LJ, Lam AC, Ovington NR, Stevens HE, Nutland S, Howson JMM, et al. 2005b. Population structure, differential bias and genomic control in a large-scale, case-control association study. Nat Genet 37:1243–1246.
  • Conrad DF, Pinto D, Redon R, Feuk L, Gokcumen O, Zhang YJ, Aerts J, Andrews TD, Barnes C, Campbell P, Fitzgerald T, Hu M, et al. 2010. Origins and functional impact of copy number variation in the human genome. Nature 464:704–712.
  • Cooper GM, Coe BP, Girirajan S, Rosenfeld JA, Vu TH, Baker C, Williams C, Stalker H, Hamid R, Hannig V, Abdel-Hamid H, Bader P, et al. 2011. A copy number variation morbidity map of developmental delay. Nat Genet 43:838–846.
  • Cooper GM, Mefford H. 2011. Detection of copy number variation using SNP genotyping. Methods Mol Biol 767:243–252.
  • Cooper GM, Zerr T, Kidd JM, Eichler EE, Nickerson DA. 2008. Systematic assessment of copy number variant detection via genome-wide SNP genotyping. Nat Genet 40:1199–1203.
  • Cukier HN, Pericak-Vance MA, Gilbert JR, Hedges DJ. 2009. Sample degradation leads to false-positive copy number variation calls in multiplex real-time polymerase chain reaction assays. Anal Biochem 386:288–290.
  • de Cid R, Riveira-Munoz E, Zeeuwen P, Robarge J, Liao W, Dannhauser EN, Giardina E, Stuart PE, Nair R, Helms C, Escaramis G, Ballana E, et al. 2009. Deletion of the late cornified envelope LCE3B and LCE3C genes as a susceptibility factor for psoriasis. Nat Genet 41:211–215.
  • den Dunnen JT, Ommen G-JB, Mathew CG. 1992. Application of pulsed-field gel electrophoresis to genetic diagnosis. Methods Mol Biol 9:313–325.
  • Dolan MJ, Kulkarni H, Camargo JF, He W, Smith A, Anaya JM, Miura T, Hecht FM, Mamtani M, Pereyra F. 2007. CCL3L1 and CCR5 influence cell-mediated immunity and affect HIV-AIDS pathogenesis via viral entry-independent mechanisms. Nat Immunol 8:1324–1336.
  • Fanciulli M, Norsworthy PJ, Petretto E, Dong R, Harper L, Kamesh L, Heward JM, Gough SCL, de Smith A, Blakemore AIF, Owen CJ, Pearce SHS, et al. 2007. FCGR3B copy number variation is associated with susceptibility to systemic, but not organ-specific, autoimmunity. Nat Genet 39:721–723.
  • Fanciulli M, Vyse TJ, Aitman TJ. 2008. Copy number variation of Fc gamma receptor genes and disease predisposition. Cytogenet Genome Res 123:161–168.
  • Fellermann K, Stange DE, Schaeffeler E, Schmalzl H, Wehkamp J, Bevins CL, Reinisch W, Teml A, Schwab M, Lichter P, Radlwimmer B, Stange EF. 2006. A chromosome 8 gene-cluster polymorphism with low human beta-defensin 2 gene copy number predisposes to Crohn disease of the colon. Am J Hum Genet 79:439–448.
  • Fernandez-Jimenez N, Castellanos-Rubio A, Plaza-Izurieta L, Gutierrez G, Castano L, Vitoria JC, Bilbao JR. 2010. Analysis of beta defensin and Toll-like receptor gene copy number variation in celiac disease. Human Immunol 71:833–836.
  • Fernando MMA, Boteva L, Morris DL, Zhou B, Wu YL, Lokki M-L, Yu CY, Rioux JD, Hollox EJ, Vyse TJ. 2010. Assessment of complement C4 gene copy number using the paralog ratio test. Hum Mutat 31:866–874.
    Direct Link:
  • Field SF, Howson JMM, Maier LM, Walker S, Walker NM, Smyth DJ, Armour JAL, Clayton DG, Todd JA. 2009. Experimental aspects of copy number variant assays at CCL3L1. Nat Med 15:1115–1117.
  • Fode P, Jespersgaard C, Hardwick RJ, Bogle H, Theisen M, Dodoo D, Lenicek M, Vitek L, Vieira A, Freitas J, Andersen PS, Hollox EJ. 2011. Determination of beta-defensin genomic copy number in different populations: a comparison of three methods. PloS One 6:e16768.
  • Fredman D, White SJ, Potter S, Eichler EE, Den Dunnen JT, Brookes AJ. 2004. Complex SNP-related sequence variation in segmental genome duplications. Nat Genet 36:861–866.
  • Girirajan S, Campbell CD, Eichler EE. 2011. Human copy number variation and complex genetic disease. Annu Rev Genet 45:203–226.
  • Girirajan S, Rosenfeld JA, Cooper GM, Antonacci F, Siswara P, Itsara A, Vives L, Walsh T, McCarthy SE, Baker C, Mefford HC, Kidd JM, et al. 2010. A recurrent 16p12.1 microdeletion supports a two-hit model for severe developmental delay. Nat Genet 42:203–209.
  • Gonzalez E, Kulkarni H, Bolivar H, Mangano A, Sanchez R, Catano G, Nibbs RJ, Freedman BI, Quinones MP, Bamshad MJ. 2005. The Influence of CCL3L1 Gene-Containing Segmental Duplications on HIV-1/AIDS Susceptibility. Science 307:1434–1440.
  • Gornalusse G, Mummidi S, Weijing H, Silvestri G, Bamshad M, Ahuja SK. 2009. CCL3L copy number variation and the co-evolution of primate and viral genomes. PLoS Genet 5:1–4.
  • Graf S, Lester S, Nossent J, Hill C, Proudman S, Lee A, Rischmueller M. 2012. Low copy number of the FCGR3B gene and rheumatoid arthritis: a case-control study and meta-analysis. Arthritis Res Ther 14:R28.
  • Groth M, Szafranski K, Taudien S, Huse K, Mueller O, Rosenstiel P, Nygren AOH, Schreiber S, Birkenmeier G, Platzer M. 2008. High-resolution mapping of the 8p23.1 beta-defensin cluster reveals strictly concordant copy number variation of all genes. Hum Mutat 29:1247–1254.
    Direct Link:
  • Grunhage F, Nattermann J, Gressner OA, Wasmuth HE, Hellerbrand C, Sauerbruch T, Spengler U, Lammert F. 2010. Lower copy numbers of the chemokine CCL3L1 gene in patients with chronic hepatitis C. J Hepatol 52:153–159.
  • Hauptmann G, Grosshans E, Heid E. 1974. Lupus erythematosus syndrome and complete deficiency of the fourth component of complement. Boll Ist Sieroter Milan Suppl 53:228.
  • He W, Kulkarni H, Castiblanco J, Shimizu C, Aluyen U, Maldonado R, Carrillo A, Griffin M, Lipsitt A, Beachy L. 2009. Reply to: “CCL3L1 and HIV/AIDS susceptibility” and “Experimental aspects of copy number variant assays at CCL3L1”. Nat Med 15:1117–1120.
  • Hinds DA, Kloek AP, Jen M, Chen X, Frazer KA. 2006. Common deletions and SNPs are in linkage disequilibrium in the human genome. Nat Genet 38:82–85.
  • Hoebeeck J, Speleman F, Vandesompele J, Hilario E, Mackay J. 2007. Real-time quantitative PCR as an alternative to southern blot or fluorescence insitu hybridization for detection of gene copy number changes. Methods Mol Biol 353:205–226.
  • Hollox EJ. 2008. Copy number variation of beta-defensins and relevance to disease. Cytogenet Genome Res 123:148–155.
  • Hollox EJ, Armour JAL, Barber JCK. 2003. Extensive normal copy number variation of a beta-defensin antimicrobial-gene cluster. Am J Hum Genet 73:591–600.
  • Hollox E, Davies J, Griesenbach U, Burgess J, Alton E, Armour J. 2005. Beta-defensin genomic copy number is not a modifier locus for cystic fibrosis. J Negat Results Biomed 4:9.
  • Hollox EJ, Detering J-C, Dehnugara T. 2009. An integrated approach for measuring copy number variation at the FCGR3 (CD16) locus. Hum Mutat 30:477–484.
    Direct Link:
  • Hollox EJ, Huffmeier U, Zeeuwen P, Palla R, Lascorz J, Rodijk-Olthuis D, van de Kerkhof PCM, Traupe H, de Jongh G, den Heijer M, Reis A, Armour JAL, et al. 2008. Psoriasis is associated with increased beta-defensin genomic copy number. Nat Genet 40:23–25.
  • Hughes AE, Orr N, Esfandiary H, Diaz-Torres M, Goodship T, Chakravarthy U. 2006. A common CFH haplotype, with deletion of CFHR1 and CFHR3, is associated with lower risk of age-related macular degeneration. Nat Genet 38:1173–1177.
  • Janssen B, Hartmann C, Scholz V, Jauch A, Zschocke J. 2005. MLPA analysis for the detection of deletions, duplications and complex rearrangements in the dystrophin gene: potential and pitfalls. Neurogenetics 6:29–35.
  • Kallioniemi A, Kallioniemi O, Sudar D, Rutovitz D, Gray J, Waldman F, Pinkel D. 1992. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 258:818–821.
  • Kastbom A, Ahmadi A, Soderkvist P, Skogh T. 2005. The 158V polymorphism of Fc gamma receptor type IIIA in early rheumatoid arthritis: increased susceptibility and severity in male patients (the Swedish TIRA project). Rheumatology 44:1294–1298.
  • Kim PM, Lam HYK, Urban AE, Korbel JO, Affourtit J, Grubert F, Chen X, Weissman S, Snyder M, Gerstein MB. 2008. Analysis of copy number variants and segmental duplications in the human genome: evidence for a change in the process of formation in recent evolutionary history. Genome Res 18:1865–1874.
  • Krumm N, Sudmant PH, Ko A, O'Roak BJ, Malig M, Coe BP, NHLBI Exome Sequencing Project N, Quinlan AR, Nickerson DA, Eichler EE. 2012. Copy number variation detection and genotyping from exome sequence data. Genome Res 22:1525–1532.
  • Kuhn La, Schramm DB, Donninger S, Meddows-Taylor S, Coovadia AH, Sherman GG, Gray GE, Tiemessen CT. 2007. African infants' CCL3 gene copies influence perinatal HIV transmission in the absence of maternal nevirapine. AIDS 21:1753–1761.
  • Kulkarni H, Marconi VC, Agan BK, McArthur C, Crawford G, Clark RA, Dolan MJ, Ahuja SK. 2008. Role of CCL3L1-CCR5 genotypes in the epidemic spread of HIV-1 and evaluation of vaccine efficacy. PloS One 3:e3671.
  • Lee H, Bae S, Choi BW, Choi JC, Yoon Y. 2011. Copy number variation of CCL3L1 influences asthma risk by modulating IL-10 expression. Clin Chim Acta 412:2100–2104.
  • Li H, Xie H-Y, Zhou L, Feng X-W, Wang W-L, Liang T-B, Zhang M, Zheng S-S. 2011. Copy number variation in CCL3L1 gene is associated with susceptibility to acute rejection in patients after liver transplantation. Clin Transplant 26:314–321.
    Direct Link:
  • Linzmeier RM, Ganz T. 2005. Human defensin gene copy number polymorphisms: comprehensive analysis of independent variation in alpha and beta defensin regions at 8p22-p23. Genomics 86:423–430.
  • Locke DP, Sharp AJ, McCarroll SA, McGrath SD, Newman TL, Cheng Z, Schwartz S, Albertson DG, Pinkel D, Altshuler DM, Eichler EE. 2006. Linkage disequilibrium and heritability of copy-number polymorphisms within duplicated regions of the human genome. Am J Hum Genet 79:275–290.
  • Lv Y, He S, Zhang Z, Li Y, Hu D, Zhu K, Cheng H, Zhou F, Chen G, Zheng X, Li P, Ren Y, et al. 2011. Confirmation of C4 gene copy number variation and the association with systemic lupus erythematosus in Chinese Han population. Rheumatol Int:1–7 [Epub ahead of print].
  • Lv J, Yang Y, Zhou X, Yu L, Li R, Hou P, Zhang H. 2010. FCGR3B copy number variation is not associated with lupus nephritis in a Chinese population. Lupus 19:158–161.
  • Machado Lee R, Hardwick Robert J, Bowdrey J, Bogle H, Knowles Timothy J, Sironi M, Hollox Edward J. 2012. Evolutionary history of copy-number-variable locus for the low-affinity fcγ receptor: mutation rate, autoimmune disease, and the legacy of Helminth infection. Am J Hum Genet 90:973–985.
  • Mamtani M, Anaya JM, He W, Ahuja SK. 2010. Association of Copy Number Variation in the FCGR3B gene with risk of autoimmune diseases. Genes Immun 11:155–160.
  • Mamtani M, Mummidi S, Ramsuran V, Pham M-H, Maldonado R, Begum K, Valera MS, Sanchez R, Castiblanco J, Kulkarni H, Ndung'u T, He W, et al. 2011. Influence of variations in CCL3L1 and CCR5 on tuberculosis in a northwestern Colombian population. J Infect Dis 203:1590–1594.
  • Mamtani M, Rovin B, Brey R, Camargo JF, Kulkarni H, Herrera M, Correa P, Holliday S, Anaya JM, Ahuja SK. 2008. CCL3L1 gene-containing segmental duplications and polymorphisms in CCR5 affect risk of systemic lupus erythaematosus. Ann Rheum Dis 67:1076–1083.
  • Marques RB, Thabet MM, White SJ, Houwing-Duistermaat JJ, Bakker AM, Hendriks GJ, Zhernakova A, Huizinga TW, van der Helm-van Mil AH, Toes RE. 2010. Genetic variation of the Fc gamma receptor 3B gene and association with rheumatoid arthritis. PloS One 5:e13173.
  • McCarroll SA. 2008. Copy-number analysis goes more than skin deep. Nat Genet 40:5–6.
  • McCarroll SA, Altshuler DM. 2007. Copy-number variation and association studies of human disease. Nat Genet 39:S37–S42.
  • McCarroll SA, Hadnott TN, Perry GH, Sabeti PC, Zody MC, Barrett JC, Dallaire S, Gabriel SB, Lee C, Daly MJ, Altshuler DM, The International HapMap C. 2006. Common deletion polymorphisms in the human genome. Nat Genet 38:86–92.
  • McCarroll SA, Huett A, Kuballa P, Chilewski SD, Landry A, Goyette P, Zody MC, Hall JL, Brant SR, Cho JH, Duerr RH, Silverberg MS, et al. 2008a. Deletion polymorphism upstream of IRGM associated with altered IRGM expression and Crohn's disease. Nat Genet 40:1107–1112.
  • McCarroll SA, Kuruvilla FG, Korn JM, Cawley S, Nemesh J, Wysoker A, Shapero MH, de Bakker PIW, Maller JB, Kirby A, Elliott AL, Parkin M, et al. 2008b. Integrated detection and population-genetic analysis of SNPs and copy number variation. Nat Genet 40:1166–1174.
  • McKinney C, Fanciulli M, Merriman ME, Phipps-Green A, Alizadeh BZ, Koeleman BPC, Dalbeth N, Gow PJ, Harrison AA, Highton J, Jones PB, Stamp LK, et al. 2010. Association of variation in Fc gamma receptor 3B gene copy number with rheumatoid arthritis in Caucasian samples. Ann Rheum Dis 69:1711–1716.
  • McKinney C, Merriman TR. 2012. Meta-analysis confirms a role for deletion in FCGR3B in autoimmune phenotypes. Hum Mol Genet 21:2370–2376.
  • McKinney C, Merriman ME, Chapman PT, Gow PJ, Harrison AA, Highton J, Jones PBB, McLean L, O'Donnell JL, Pokorny V. 2008. Evidence for an influence of chemokine ligand 3-like 1 (CCL3L1) gene copy number on susceptibility to rheumatoid arthritis. Ann Rheum Dis 67:409–413.
  • Meddows-Taylor S, Donninger SL, Paximadis M, Schramm DB, Anthony FS, Gray GE, Kuhn L, Tiemessen CT. 2006. Reduced ability of newborns to produce CCL3 is associated with increased susceptibility to perinatal human immunodeficiency virus 1 transmission. J Gen Virol 87:2055–2065.
  • Milicic A, Misra R, Agrawal S, Aggarwal A, Brown MA, Wordsworth BP. 2002. The F158V polymorphism in FCGRIIIA shows disparate associations with rheumatoid arthritis in two genetically distinct populations. Ann Rheum Dis 61:1021–1023.
  • Mills RE, Walter K, Stewart C, Handsaker RE, Chen K, Alkan C, Abyzov A, Yoon SC, Ye K, Cheetham RK, Chinwalla A, Conrad DF, et al. 2011. Mapping copy number variation by population-scale genome sequencing. Nature 470:59–65.
  • Molokhia M, Fanciulli M, Petretto E, Patrick AL, McKeigue P, Roberts AL, Vyse TJ, Aitman TJ. 2011. FCGR3B copy number variation is associated with systemic lupus erythematosus risk in Afro-Caribbeans. Rheumatology 50:1206–1210.
  • Morgan A, Barrett J, Griffiths B, Subramanian D, Robinson J, Keyte V, Ali M, Jones E, Old R, Ponchel F, Boylston A, Situnayake RD, et al. 2006. Analysis of Fc gamma receptor haplotypes in rheumatoid arthritis: FCGR3A remains a major susceptibility gene at this locus, with an additional contribution from FCGR3B. Arthritis Res Ther 8:R5.
  • Morgan AW, Keyte VH, Babbage SJ, Robinson JI, Ponchel F, Barrett JH, Bhakta BB, Bingham SJ, Buch MH, Conaghan PG, Gough A, Green M, et al. 2003. FCGR3A-158V and rheumatoid arthritis: a confirmation study. Rheumatology 42:528–533.
  • Morris DL, Roberts AL, Witherden AS, Tarzi R, Barros P, Whittaker JC, Cook TH, Aitman TJ, Vyse TJ. 2010. Evidence for both copy number and allelic (NA1/NA2) risk at the FCGR3B locus in systemic lupus erythematosus. Eur J Hum Genet 18:1027–1031.
  • Nakajima T, Ohtani H, Naruse T, Shibata H, Mimaya J-I, Terunuma H, Kimura A. 2007. Copy number variations of CCL3L1 and long-term prognosis of HIV-1 infection in asymptomatic HIV-infected Japanese with hemophilia. Immunogenetics 59:793–798.
  • Niederer HA, Willcocks LC, Rayner TF, Yang W, Lau YL, Williams TN, Scott JAG, Urban BC, Peshu N, Dunstan SJ, Hien TT, Phu NH, et al. 2010. Copy number, linkage disequilibrium and disease association in the FCGR locus. Hum Mol Genet 19:3282–3294.
  • Notini AJ, Craig JM, White SJ. 2009. Copy number variation and mosaicism. Cytogenet Genome Res 123:270–277.
  • O'Roak BJ, Deriziotis P, Lee C, Vives L, Schwartz JJ, Girirajan S, Karakoc E, MacKenzie AP, Ng SB, Baker C, Rieder MJ, Nickerson DA, et al. 2011. Exome sequencing in sporadic autism spectrum disorders identifies severe de novo mutations. Nat Genet 43:585–589.
  • Perne A, Zhang X, Lehmann LE, Groth M, Stuber F, Book M. 2009. Comparison of multiplex ligation-dependant probe amplification and real time PCR accuracy for gene copy number quantification using the beta defensin locus. Biotechniques 47:1023–1026.
  • Perry GH, Dominy NJ, Claw KG, Lee AS, Fiegler H, Redon R, Werner J, Villanea FA, Mountain JL, Misra R, Carter NP, Lee C, et al. 2007. Diet and the evolution of human amylase gene copy number variation. Nat Genet 39:1256–1260.
  • Petrij-Bosch A, Peelen T, van Vliet M, Eijk Rv, Olmer R, Drusedau M, Hogervorst FBL, Hageman S, Arts PJW, Ligtenberg MJL, Meijers-Heijboer H, Klijn JGM, et al. 1997. BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients. Nat Genet 17:341–345.
  • Pinkel D, Seagraves R, Sudar D, Clark S, Poole I, Kowbel D, Collins C, Kuo WL, Chen C, Zhai Y, Dairkee SH, Ljung BM, et al. 1998. High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays. Nat Genet 20:207–211.
  • Plagnol V. 2009. Association tests and software for copy number variant data. Hum Genomics 3:191–194.
  • Redon R, Ishikawa S, Fitch KR, Feuk L, Perry GH, Andrews TD, Fiegler H, Shapero MH, Carson AR, Chen W. 2006. Global variation in copy number in the human genome. Nature 444:444–454.
  • Rigby WFC, Wu YL, Zan M, Zhou B, Rosengren S, Carlson C, Hilton W, Yu CY. 2012. Increased frequency of complement C4B deficiency in rheumatoid arthritis. Arthritis Rheum 64:1338–1344.
    Direct Link:
  • Robinson JI, Carr IM, Cooper DL, Rashid LH, Martin SG, Emery P, Isaacs JD, Barton A, Braggss, Wilson AG, Barrett JH, Morgan AW. 2012. Confirmation of association of FCGR3B but not FCGR3A copy number with susceptibility to autoantibody positive rheumatoid arthritis. Hum Mutat 33:741–749.
    Direct Link:
  • Rovelet-Lecrux A, Hannequin D, Raux G, Meur NL, Laquerriere A, Vital A, Dumanchin C, Feuillette S, Brice A, Vercelletto M, Dubas F, Frebourg T, et al. 2006. APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy. Nat Genet 38:24–26.
  • Schouten JP, McElgunn CJ, Waaijer R, Zwijnenburg D, Diepvens F, Pals G. 2002. Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucleic Acids Res 30:1–13.
  • Schrider DR, Hahn MW. 2010. Lower linkage disequilibrium at CNVs is due to both recurrent mutation and transposing duplications. Mol Biol Evol 27:103–111.
  • Shalekoff S, Meddows-Taylor S, Schramm DB, Donninger SL, Gray GE, Sherman GG, Coovadia AH, Kuhn L, Tiemessen CT. 2008. Host CCL3L1 gene copy number in relation to HIV-1-specific CD4+ and CD8+ T-cell responses and viral load in South African women. J Acquir Immune Defic Syndr 48:245–254.
  • Shao W, Tang J, Song W, Wang C, Li Y, Wilson CM, Kaslow RA. 2007. CCL3L1 and CCL4L1: variable gene copy number in adolescents with and without human immunodeficiency virus type 1 (HIV-1) infection. Genes Immun 8:224–231.
  • Sharp AJ, Hansen S, Selzer RR, Cheng Z, Regan R, Hurst JA, Stewart H, Price SM, Blair E, Hennekam RC, Fitzpatrick CA, Segraves R, et al. 2006. Discovery of previously unidentified genomic disorders from the duplication architecture of the human genome. Nat Genet 38:1038–1042.
  • Sharp AJ, Locke DP, McGrath SD, Cheng Z, Bailey JA, Vallente RU, Pertz LM, Clark RA, Schwartz S, Segraves R, Oseroff VV, Albertson DG, et al. 2005. Segmental duplications and copy-number variation in the human genome. Am J Hum Genet 77:78–88.
  • Shostakovich-Koretskaya La, Catano Gbc, Chykarenko ZAa, He Wbc, Gornalusse Gbc, Mummidi Sbc, Sanchez Rbc, Dolan MJde, Ahuja SSbc, Clark RAbc, Kulkarni Hbc, Ahuja SKbcf. 2009. Combinatorial content of CCL3L and CCL4L gene copy numbers influence HIV-AIDS susceptibility in Ukrainian children. AIDS 23:679–688.
  • Stranger BE, Forrest MS, Dunning M, Ingle CE, Beazley C, Thorne N, Redon R, Bird CP, de Grassi A, Lee C. 2007. Relative impact of nucleotide and copy number variation on gene expression phenotypes. Science 315:848–853.
  • Stuart PE, Huffmeier U, Nair RP, Palla R, Tejasvi T, Schalkwijk J, Elder JT, Reis A, Armour JAL. 2012. Association of beta-defensin copy number and psoriasis in three cohorts of European origin. J Invest Dermatol. doi:10.1038/jid.2012.191. [Epub ahead of print]
  • Sudmant PH, Kitzman JO, Antonacci F, Alkan C, Malig M, Tsalenko A, Sampas N, Bruhn L, Shendure J, Genomes P, Eichler EE. 2010. Diversity of human copy number variation and multicopy genes. Science 330:641–646.
  • Thabet MM, Huizinga TWJ, Marques RB, Stoeken-Rijsbergen G, Bakker AM, Kurreeman FA, White SJ, Toes REM, van der Helm-van Mil AHM. 2009. Contribution of Fc gamma receptor IIIA gene 158V/F polymorphism and copy number variation to the risk of ACPA-positive rheumatoid arthritis. Ann Rheum Dis 68:1775–1780.
  • The Wellcome Trust Case Control Consortium. 2010. Genome-wide association study of CNVs in 16,000 cases of eight common diseases and 3,000 shared controls. Nature 464:713–720.
  • Tuzun E, Sharp AJ, Bailey JA, Kaul R, Morrison VA, Pertz LM, Haugen E, Hayden H, Albertson D, Pinkel D, Olson MV, Eichler EE. 2005. Fine-scale structural variation of the human genome. Nat Genet 37:727–732.
  • Uko G, Christiansen F, Dawkins R, Kay P. 1983. Low serum C4 concentrations in insulin dependent diabetes mellitus. Br Med J 286:1748–1749.
  • Urban TJ, Weintrob AC, Fellay J, Colombo S, Shianna KV, Gumbs C, Rotger M, Pelak K, Dang KK, Detels R. 2009. CCL3L1 and HIV/AIDS susceptibility. Nat Med 15:1110–1112.
  • Vergani D, Johnston C, Abdullah N, Barnett A. 1983. Low serum C4 concentrations: an inherited predisposition to insulin dependant diabetes? Br Med J 286:926–928.
  • Walker S, Janyakhantikul S, Armour JAL. 2009. Multiplex paralogue ratio tests for accurate measurement of multiallelic CNVs. Genomics 93:98–103.
  • White SJ, Breuning MH, den Dunnen JT. 2004. Detecting copy number changes in genomic DNA: MAPH and MLPA. Methods Mol Biol 75:751–768.
  • Willcocks LC, Lyons PA, Clatworthy MR, Robinson JI, Yang W, Newland SA, Plagnol V, McGovern NN, Condliffe AM, Chilvers ER, Adu D, Jolly EC, et al. 2008. Copy number of FCGR3B, which is associated with systemic lupus erythematosus, correlates with protein expression and immune complex uptake. J Exp Med 205:1573–1582.
  • Willer C. 2009. Six new loci associated with body mass index highlight a neuronal influence on body weight regulation. Nat Genet 41:25–34.
  • Wu YL, Hauptmann G, Viguier M, Yu CY. 2009. Molecular basis of complete complement C4 deficiency in two North-African families with systemic lupus erythematosus. Genes Immun 10:433–445.
  • Wu YL, Savelli SL, Yang Y, Zhou B, Rovin BH, Birmingham DJ, Nagaraja HN, Hebert LA, Yu CY. 2007. Sensitive and specific real-time polymerase chain reaction assays to accurately determine copy number variations (CNVs) of human complement C4A, C4B, C4-long, C4-short, and RCCX modules: elucidation of C4 CNVs in 50 consanguineous subjects with defined HLA genotypes. J Immunol 179:3012–3025.
  • Xu B, Roos JL, Levy S, van Rensburg EJ, Gogos JA, Karayiorgou M. 2008. Strong association of de novo copy number mutations with sporadic schizophrenia. Nat Genet 40:880–885.
  • Yang Y, Chung EK, Wu YL, Savelli SL, Nagaraja HN, Zhou B, Hebert M, Jones KN, Shu YL, Kitzmiller K, Blanchong CA, McBride KL, et al. 2007. Gene copy-number variation and associated polymorphisms of complement component C4 in human systemic lupus erythematosus (SLE): low copy number is a risk factor for and high copy number is a protective factor against SLE susceptibility in European Americans. Am J Hum Genet 80:1037–1054.
  • Ye K, Schulz MH, Long Q, Apweiler R, Ning Z. 2009. Pindel: a pattern growth approach to detect break points of large deletions and medium sized insertions from paired-end short reads. Bioinformatics 25:2865–2871.
View Full Article (HTML) Get PDF (354K)